Calidi BiotherapeuticsCLDI
13F holders, Q4 2025 (December 31)27holders +5
8new positions
3sold out
$1.17avg. 13F price*
At the end of Q4 2025, 27 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, up 5 from Q3 2025. 8 opened new positions and 3 sold out. The largest holders were DRW Securities, LLC ($173K), HighTower Advisors, LLC ($98K) and Geode Capital Management, LLC ($49K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $247K |
| Exits | 3 | $29K |
All 13F filers, Q3 2025 → Q4 2025: 258,289 shares bought and 21,414 shares sold, net +236,875 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| DRW Securities, LLC | 0.01% | New | 147,767 | $173K |
| HighTower Advisors, LLC | 0.00% | Reduce -1.7% | 83,523 | $98K |
| Geode Capital Management, LLC | 0.00% | Add +41.7% | 41,929 | $49K |
| Vanguard Group Inc. | 0.00% | No change | 34,728 | $41K |
| FMR LLC | 0.00% | Add +17510.4% | 22,013 | $26K |
| Virtu Financial LLC | 0.00% | New | 21,243 | $25K |
| RS Crum Inc. | 0.00% | Add +32.8% | 20,256 | $24K |
| Belpointe Asset Management LLC | 0.00% | Reduce -4.1% | 19,971 | $23K |
| Northern Trust Corp. | 0.00% | New | 17,758 | $21K |
| Jane Street Group, LLC | 0.00% | New | 11,491 | $13K |
| Farther Finance Advisors, LLC | 0.00% | New | 10,000 | $12K |
| UBS Group AG | 0.00% | Add +193.1% | 7,514 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,774 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +1332.7% | 2,106 | $2K |
| Morgan Stanley | 0.00% | Add +279.1% | 1,467 | $2K |
| Finepoint Capital LP | 0.00% | No change | 1,042 | $1K |
| Apollo Management Holdings, L.P. | 0.00% | No change | 1,042 | $1K |
| Highbridge Capital Management LLC | 0.00% | No change | 1,042 | $1K |
| Barrett & Company, Inc. | 0.00% | No change | 292 | $342 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 101 | $119 |
| Reyes Financial Architecture, Inc. | 0.00% | No change | 100 | $117 |
| SBI Securities Co., Ltd. | 0.00% | No change | 46 | $54 |
| Bank of America Corp. | 0.00% | Add +53.3% | 46 | $53 |
| CVA Family Office, LLC | 0.00% | No change | 42 | $49 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 28 | $33 |
| Evermay Wealth Management LLC | 0.00% | No change | 1 | $2 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.